NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Manas AI

Manas AI

Private
New York City, New YorkAI, Data & Cloud Infrastructurehttps://www.manasai.co/

Last Round

Seed

Sep 23, 2025

Total Funding Raised

$50.6M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Manas AI is a biopharmaceutical company that develops an artificial intelligence-driven drug discovery platform designed to accelerate the development of treatments for cancer, autoimmune diseases, and rare conditions.

Sector

AI, Data & Cloud Infrastructure

Verticals

Workflow Automation, Business Intelligence, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Foundation

Keywords

drug discoverygenerative chemistrybiopharmaceuticalfoundational modelsneuro-symbolic aiai drug discoverymolecular bindingcandidate optimizationtarget identificationbiotech aiphysics-based simulationin silico discoverytherapeutic pipelinefrontier ai lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Manas AI Comparables

Compare Manas AI with similar companies based on industry and business-model similarity.

Manas AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Numerion Labs
73%
Causaly
36%
EvolutionaryScale
36%

Manas AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 23, 2025
SeedJan 27, 2025

Key People

Founding team and executive leadership

Erez Kalir

Board Member, Advisor, Acting COO

Executive Team

Manas AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Grew 44% QoQ, from 18 to 26 employees.

  • Apr 27, 2026

    Grew 59% QoQ from 17 to 27 employees.

Manas AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Manas AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Manas AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range26
Year Founded2025
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.